AT374477B - Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen - Google Patents

Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen

Info

Publication number: AT374477B
Authority: AT; Austria
Prior art keywords: cycloalkyltriazoles; salts; producing new; producing; new
Prior art date: 1978-04-18

Application number

AT0292479A

Other languages

English (en)

Other versions

ATA292479A (de

Original Assignee

Acraf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-04-18

Filing date

1979-04-18

Publication date

1984-04-25

1979-04-18 Application filed by Acraf filed Critical Acraf

1982-08-10 Priority to AT305982A priority Critical patent/AT380251B/de

1983-09-15 Publication of ATA292479A publication Critical patent/ATA292479A/de

1984-04-25 Application granted granted Critical

1984-04-25 Publication of AT374477B publication Critical patent/AT374477B/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT0292479A 1978-04-18 1979-04-18 Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen AT374477B (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AT305982A AT380251B (de)	1978-04-18	1982-08-10	Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT22421/78A IT1094076B (it)	1978-04-18	1978-04-18	Cicloalchiltriazoli

Publications (2)

Publication Number	Publication Date
ATA292479A ATA292479A (de)	1983-09-15
AT374477B true AT374477B (de)	1984-04-25

Family

ID=11196066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0292479A AT374477B (de)	1978-04-18	1979-04-18	Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen

Country Status (22)

Country	Link
US (2)	US4252721A (de)
JP (1)	JPS5817757B2 (de)
AT (1)	AT374477B (de)
AU (1)	AU520788B2 (de)
BG (2)	BG40654A3 (de)
CA (1)	CA1104567A (de)
CH (1)	CH639847A5 (de)
DE (1)	DE2915318A1 (de)
DK (1)	DK148480C (de)
FI (1)	FI66378C (de)
FR (1)	FR2423221A1 (de)
GB (1)	GB2020269B (de)
HU (1)	HU179917B (de)
IE (1)	IE47965B1 (de)
IL (1)	IL56926A (de)
IT (1)	IT1094076B (de)
NL (1)	NL186635C (de)
PL (1)	PL116103B1 (de)
PT (1)	PT69502A (de)
SE (1)	SE437663B (de)
SU (1)	SU852174A3 (de)
YU (1)	YU41338B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1248531A (en) *	1984-04-17	1989-01-10	Jeffrey C. Watkins	4-substituted piperazine-2-carboxylic acids
FR2580648B1 (fr) *	1985-04-17	1987-05-15	Adir	Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4879294A (en) *	1988-01-28	1989-11-07	Angelini Pharmaceuticals Ltd.	Opthalmic composition
IT1224250B (it) *	1988-06-10	1990-09-26	Acraf	Associzione del depiprazolo con la morfina
IT1250701B (it) *	1991-07-24	1995-04-21	Angelini Francesco Ist Ricerca	Composizione farmaceutica solida per uso orale a base di dapiprazolo
US5288759A (en) *	1992-08-27	1994-02-22	Alcon Laboratories, Inc.	Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
US6187774B1 (en)	1996-03-04	2001-02-13	Yoshitomi Pharmaceutical Industries, Ltd.	Fused heterocyclic compounds and pharmaceutical applications thereof
WO2000018391A1 (fr)	1998-09-30	2000-04-06	Takeda Chemical Industries, Ltd.	Medicaments qui ameliorent le pouvoir de vidange de la vessie
IL141235A (en) *	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
US6730691B1 (en)	2000-02-10	2004-05-04	Miles A. Galin	Uses of alpha adrenergic blocking agents
US20020065286A1 (en) *	2000-08-21	2002-05-30	Davies Michael John	Treatment of wounds
US20020091129A1 (en) *	2000-11-20	2002-07-11	Mitradev Boolell	Treatment of premature ejaculation
WO2003004058A1 (en) *	2001-07-02	2003-01-16	Santen Pharmaceutical Co., Ltd.	OPTIC NERVE PROTECTING AGENTS CONTAINING α1 RECEPTOR BLOCKER AS THE ACTIVE INGREDIENT
GB0130219D0 (en) *	2001-12-18	2002-02-06	Pfizer Ltd	Compounds for the treatment of sexual dysfunction
US20030229001A1 (en) *	2002-01-31	2003-12-11	Pfizer Inc.	Treatment of male sexual dysfunction
CA2495962A1 (en)	2002-08-19	2004-03-04	Pfizer Products Inc.	Combination therapy for hyperproliferative diseases
GB0219961D0 (en)	2002-08-28	2002-10-02	Pfizer Ltd	Oxytocin inhibitors
US7323462B2 (en) *	2002-12-10	2008-01-29	Pfizer Inc.	Morpholine dopamine agonists
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
PA8597401A1 (es) *	2003-03-14	2005-05-24	Pfizer	Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) *	2003-04-30	2004-11-04	Pfizer Inc.	PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
CN101967117A (zh) *	2003-05-30	2011-02-09	兰贝克赛实验室有限公司	取代的吡咯衍生物及其作为hmg-co抑制剂的用途
US20050065158A1 (en) *	2003-07-16	2005-03-24	Pfizer Inc.	Treatment of sexual dysfunction
US20050037063A1 (en) *	2003-07-21	2005-02-17	Bolton Anthony E.	Combined therapies
US7291640B2 (en) *	2003-09-22	2007-11-06	Pfizer Inc.	Substituted triazole derivatives as oxytocin antagonists
US20050267096A1 (en) *	2004-05-26	2005-12-01	Pfizer Inc	New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) *	2004-05-27	2005-12-29	Pfizer Inc	New aminopyridine derivatives and their use as pharmaceuticals
WO2006100588A1 (en) *	2005-03-21	2006-09-28	Pfizer Limited	Substituted triazole derivatives as oxytocin antagonists
WO2006100557A1 (en) *	2005-03-21	2006-09-28	Pfizer Limited	Substituted triazole derivatives as oxytocin antagonists
EP1917257A1 (de) *	2005-08-10	2008-05-07	Pfizer Limited	Substituierte triazolderivate als oxytocin-antagonisten
GT200600381A (es)	2005-08-25	2007-03-28		Compuestos organicos
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
JP2009514851A (ja) *	2005-11-08	2009-04-09	ランバクシーラボラトリーズリミテッド	（３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US20070238716A1 (en) *	2006-03-14	2007-10-11	Murthy Ayanampudi S R	Statin stabilizing dosage formulations
BRPI0714361A2 (pt) *	2006-07-14	2013-03-26	Ranbaxy Lab Ltd	polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
ES2382009T3 (es)	2006-12-01	2012-06-04	Bristol-Myers Squibb Company	Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
BR112015026513A2 (pt)	2013-04-17	2017-07-25	Pfizer	derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
MX2021004708A (es)	2018-10-26	2021-11-03	Ocuphire Pharma Inc	Metodos y composiciones para tratamiento de presbicia, midriasis y otros trastornos oculares.
MX2021008533A (es)	2019-01-18	2021-08-19	Astrazeneca Ab	Inhibidores de la pcsk9 y metodos de uso de los mismos.
CN115368310A (zh)	2021-05-18	2022-11-22	奥库菲尔医药公司	合成甲磺酸酚妥拉明的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2913454A (en) *	1956-11-23	1959-11-17	Schenley Ind Inc	Certain cycloalkanotriazoles, process and intermediates
IT1066857B (it) *	1965-12-15	1985-03-12	Acraf	Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US3472853A (en) *	1967-05-29	1969-10-14	Sterling Drug Inc	1-((pyrido(2,1-c)-s-triazolyl)-lower-alkyl)-4-substituted- piperazines
JPS5070389A (de) *	1973-10-30	1975-06-11

1978
- 1978-04-18 IT IT22421/78A patent/IT1094076B/it active Protection Beyond IP Right Term
1979
- 1979-03-22 CH CH268579A patent/CH639847A5/it not_active IP Right Cessation
- 1979-03-22 IL IL56926A patent/IL56926A/xx unknown
- 1979-03-29 US US06/025,273 patent/US4252721A/en not_active Expired - Lifetime
- 1979-03-30 NL NLAANVRAGE7902489,A patent/NL186635C/xx not_active IP Right Cessation
- 1979-04-09 AU AU45832/79A patent/AU520788B2/en not_active Ceased
- 1979-04-11 GB GB7912875A patent/GB2020269B/en not_active Expired
- 1979-04-11 FR FR7909229A patent/FR2423221A1/fr active Granted
- 1979-04-11 YU YU862/79A patent/YU41338B/xx unknown
- 1979-04-12 FI FI791217A patent/FI66378C/fi not_active IP Right Cessation
- 1979-04-14 DE DE19792915318 patent/DE2915318A1/de active Granted
- 1979-04-17 HU HU79AI284A patent/HU179917B/hu unknown
- 1979-04-17 PT PT69502A patent/PT69502A/pt unknown
- 1979-04-17 CA CA325,782A patent/CA1104567A/en not_active Expired
- 1979-04-17 SE SE7903327A patent/SE437663B/sv not_active IP Right Cessation
- 1979-04-17 DK DK156779A patent/DK148480C/da not_active IP Right Cessation
- 1979-04-17 SU SU792753553A patent/SU852174A3/ru active
- 1979-04-18 AT AT0292479A patent/AT374477B/de not_active IP Right Cessation
- 1979-04-18 PL PL1979214969A patent/PL116103B1/pl unknown
- 1979-04-18 JP JP54048519A patent/JPS5817757B2/ja not_active Expired
- 1979-04-18 BG BG043291A patent/BG40654A3/xx unknown
- 1979-08-08 IE IE646/79A patent/IE47965B1/en not_active IP Right Cessation
1980
- 1980-08-29 US US06/182,426 patent/US4307095A/en not_active Expired - Lifetime
1994
- 1994-02-25 BG BG098586A patent/BG61367B2/bg unknown

Also Published As

Publication number	Publication date
YU41338B (en)	1987-02-28
FI66378B (fi)	1984-06-29
DK156779A (da)	1979-10-19
IT7822421A0 (it)	1978-04-18
BG61367B2 (bg)	1997-06-30
JPS5817757B2 (ja)	1983-04-09
DE2915318A1 (de)	1979-10-31
HU179917B (en)	1983-01-28
CA1104567A (en)	1981-07-07
US4307095A (en)	1981-12-22
YU86279A (en)	1983-12-31
FR2423221A1 (fr)	1979-11-16
SE437663B (sv)	1985-03-11
GB2020269A (en)	1979-11-14
DK148480C (da)	1985-12-16
SU852174A3 (ru)	1981-07-30
IE47965B1 (en)	1984-08-08
IL56926A (en)	1983-09-30
AU520788B2 (en)	1982-02-25
PL116103B1 (en)	1981-05-30
BG40654A3 (en)	1987-01-15
DE2915318C2 (de)	1990-12-13
NL186635C (nl)	1991-01-16
IT1094076B (it)	1985-07-26
ATA292479A (de)	1983-09-15
PT69502A (en)	1979-05-01
JPS54157576A (en)	1979-12-12
GB2020269B (en)	1982-06-03
PL214969A1 (de)	1980-03-10
FI791217A (fi)	1979-10-19
DK148480B (da)	1985-07-15
SE7903327L (sv)	1979-10-19
NL7902489A (nl)	1979-10-22
AU4583279A (en)	1979-10-25
FI66378C (fi)	1984-10-10
IL56926A0 (en)	1979-05-31
FR2423221B1 (de)	1983-03-18
CH639847A5 (it)	1983-12-15
NL186635B (nl)	1990-08-16
US4252721A (en)	1981-02-24
IE790646L (en)	1979-10-18

Publication	Publication Date	Title
AT374477B (de)	1984-04-25	Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
AT373887B (de)	1984-02-27	Verfahren zur herstellung von neuen n-heterocyclyl-4-piperidinaminen und deren saeureadditionssalzen
ATA601078A (de)	1981-04-15	Verfahren zur herstellung von neuen nitro- imidazolen und von deren salzen
AT374188B (de)	1984-03-26	Verfahren zur herstellung von neuen a-alkylimidazolderivaten und deren salzen
AT366662B (de)	1982-04-26	Verfahren zur herstellung von neuen 1-aryloxy-3- nitratoalkylamino-2-propanolen und deren saeureadditionssalzen
AT370408B (de)	1983-03-25	Verfahren zur herstellung von neuen phenylaethanolaminen und von salzen hiervon
ATA463779A (de)	1982-01-15	Verfahren zur herstellung von neuen phenylaethanolaminen und salzen hirvon
ATA204479A (de)	1983-01-15	Verfahren zur herstellung von neuen n-oxacyclyl- alkyl-piperidyl-daizaverbindungen und von deren salzen
AT372956B (de)	1983-12-12	Verfahren zur herstellung von 2-aminopyrimidonen und von deren salzen
AT372085B (de)	1983-08-25	Verfahren zur herstellung von neuen substituierten diphenyl-imidazolyl-methanen und von deren salzen
AT369731B (de)	1983-01-25	Verfahren zur herstellung von neuen 4-pyridon-3-carbonsaeurederivaten und deren salzen
AT376967B (de)	1985-01-25	Verfahren zur herstellung von neuen furylverbindungen und von deren salzen
AT365188B (de)	1981-12-28	Verfahren zur herstellung von neuen 7-azabenzimidazolen und deren salzen
ATA123879A (de)	1980-12-15	Verfahren zur herstellung von neuen acylierten aminoalkyl-cyanoguanidinen und deren salzen
AT377767B (de)	1985-04-25	Verfahren zur herstellung von neuen 4-aza-17subst.-5alpha-androstan-3-onen und deren pharmazeutisch verwendbaren salzen
AT360999B (de)	1981-02-10	Verfahren zur herstellung von neuen amidino- -benzylpyrimidinen und deren salzen
AT372081B (de)	1983-08-25	Verfahren zur herstellung von neuen substituierten n-iminomethylpiperidinen und von deren saeureadditionssalzen
AT367752B (de)	1982-07-26	Verfahren zur herstellung von neuen 4-hydroxy-2- benzimidazolin-thion-derivaten und von deren salzen
AT370083B (de)	1983-02-25	Verfahren zur herstellung von neuen aminen und deren salzen
AT358050B (de)	1980-08-11	Verfahren zur herstellung von neuen triazolo- thieno-diazepin-1-onen und deren salzen
ATA320578A (de)	1980-03-15	Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen
AT366665B (de)	1982-04-26	Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
ATA315781A (de)	1984-02-15	Verfahren zur herstellung von neuen pyridinylaminophenolen und deren salzen
ATA305982A (de)	1985-09-15	Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
ATA144581A (de)	1983-08-15	Verfahren zur herstellung von neuen phenylessig- saeure-derivaten und deren salzen

Legal Events

Date	Code	Title	Description
1980-04-15	ELJ	Ceased due to non-payment of the annual fee
2002-05-15	ELA	Expired due to lapse of time